Showing results (11-20 of 58) with videos related to
Sort By:
Pageof 6
Journal of Surgical Oncology|October 10, 2024
Preoperative Glycosylated Hemoglobin A1C Impacts Long-Term Outcomes Following Curative-Intent Resection of Nonfunctional Gastroenteropancreatic Neuroendocrine TumorsMu-Xing Li, Alexandra G Lopez-Aguiar, George Poultsides, et al.Journal of Surgical Oncology|July 25, 2019
Association of preoperative monocyte-to-lymphocyte and neutrophil-to-lymphocyte ratio with recurrence-free and overall survival after resection of pancreatic neuroendocrine tumors (US-NETSG)Roheena Z Panni, Alexandra G Lopez-Aguiar, Jingxia Liu, et al.Journal of Surgical Oncology|November 28, 2018
The impact of failure to achieve symptom control after resection of functional neuroendocrine tumors: An 8-institution study from the US Neuroendocrine Tumor Study GroupMohammad Y Zaidi, Alexandra G Lopez-Aguiar, George A Poultsides, et al.Journal of Surgical Oncology|May 30, 2020
Surgical outcomes of patients with duodenal vs pancreatic neuroendocrine tumors following pancreatoduodenectomyDing-Hui Dong, Xu-Feng Zhang, Alexandra G Lopez-Aguiar, et al.Journal of Surgical Oncology|October 24, 2019
Optimizing cancer care for hepatocellular carcinoma at a safety-net hospital: The value of a multidisciplinary disease management teamGrace Duininck, Alexandra G Lopez-Aguiar, Rachel M Lee, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 31, 2019
STAT3 Inhibition for Gastroenteropancreatic Neuroendocrine Tumors: Potential for a New Therapeutic Target?Alexandra G Lopez-Aguiar, Lauren M Postlewait, Cecilia G Ethun, et al.Surgery|May 11, 2019
The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical managementAlexandra G Lopez-Aguiar, Cecilia G Ethun, Mohammad Y Zaidi, et al.Journal of Surgical Oncology|August 7, 2019
Interaction of race and pathology for neuroendocrine tumors: Epidemiology, natural history, or racial disparity?Danielle K DePalo, Rachel M Lee, Alexandra G Lopez-Aguiar, et al.Annals of Surgical Oncology|October 29, 2017
Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors: Improving Its Prognostic Value for Recurrence of DiseaseAlexandra G Lopez-Aguiar, Cecilia G Ethun, Lauren M Postlewait, et al.Surgical Oncology|October 20, 2020
HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for a novel therapeutic targetAdriana C Gamboa, Cecilia G Ethun, Lauren M Postlewait, et al.Pageof 6